Follow
Vilma A. Sardao
Vilma A. Sardao
Centre for Neuroscience and Cell Biology
Verified email at ci.uc.pt
Title
Cited by
Cited by
Year
Mitochondrial determinants of doxorubicin-induced cardiomyopathy
KB Wallace, VA Sardão, PJ Oliveira
Circulation research 126 (7), 926-941, 2020
3392020
Mitochondria and reactive oxygen species in aging and age-related diseases
C Giorgi, S Marchi, ICM Simoes, Z Ren, G Morciano, M Perrone, ...
International review of cell and molecular biology 340, 209-344, 2018
2452018
Reactivation of dihydroorotate dehydrogenase-driven pyrimidine biosynthesis restores tumor growth of respiration-deficient cancer cells
M Bajzikova, J Kovarova, AR Coelho, S Boukalova, S Oh, K Rohlenova, ...
Cell metabolism 29 (2), 399-416. e10, 2019
2052019
Ketogenic diets: from cancer to mitochondrial diseases and beyond
AF Branco, A Ferreira, RF Simões, S Magalhães‐Novais, C Zehowski, ...
European journal of clinical investigation 46 (3), 285-298, 2016
1822016
Phytoestrogens as alternative hormone replacement therapy in menopause: What is real, what is unknown
AC Moreira, AM Silva, MS Santos, VA Sardao
The Journal of steroid biochemistry and molecular biology 143, 61-71, 2014
1702014
Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line
TL Serafim, PJ Oliveira, VA Sardao, E Perkins, D Parke, J Holy
Cancer Chemotherapy and Pharmacology 61, 1007-1018, 2008
1652008
Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets
VA Sardão, PJ Oliveira, J Holy, CR Oliveira, KB Wallace
Cell biology and toxicology 25, 227-243, 2009
1632009
Mitochondrially targeted effects of berberine [Natural Yellow 18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium] on K1735-M2 mouse melanoma …
GC Pereira, AF Branco, JAC Matos, SL Pereira, D Parke, EL Perkins, ...
Journal of pharmacology and experimental therapeutics 323 (2), 636-649, 2007
1492007
Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats
A Ascensão, J Lumini-Oliveira, NG Machado, RM Ferreira, IO Gonçalves, ...
Clinical science 120 (1), 37-49, 2011
1472011
Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts
VA Sardão, PJ Oliveira, J Holy, CR Oliveira, KB Wallace
Cancer chemotherapy and pharmacology 64, 811-827, 2009
1162009
Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety?
CV Pereira, AC Moreira, SP Pereira, NG Machado, FS Carvalho, ...
Current drug safety 4 (1), 34-54, 2009
1162009
Vital imaging of H9c2 myoblasts exposed to tert-butylhydroperoxide – characterization of morphological features of cell death
VA Sardão, PJ Oliveira, J Holy, CR Oliveira, KB Wallace
BMC Cell Biology 8, 1-15, 2007
832007
Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies
SL Pereira, J Ramalho-Santos, AF Branco, VA Sardao, PJ Oliveira, ...
Cardiovascular toxicology 11, 180-190, 2011
802011
Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line
AF Branco, SL Pereira, AC Moreira, J Holy, VA Sardão, PJ Oliveira
Cardiovascular toxicology 11, 191-203, 2011
722011
The mitochondrial permeability transition pore: an evolving concept critical for cell life and death
G Morciano, N Naumova, P Koprowski, S Valente, VA Sardão, Y Potes, ...
Biological Reviews 96 (6), 2489-2521, 2021
712021
Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors
HN Kim, F Ponte, I Nookaew, S Ucer Ozgurel, A Marques-Carvalho, S Iyer, ...
Scientific reports 10 (1), 11933, 2020
662020
Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts
AF Branco, SF Sampaio, AC Moreira, J Holy, KB Wallace, I Baldeiras, ...
Cardiovascular toxicology 12, 326-340, 2012
662012
Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells—Nuclear vs. mitochondrial effects
TL Serafim, JAC Matos, VA Sardao, GC Pereira, AF Branco, SL Pereira, ...
biochemical pharmacology 76 (11), 1459-1475, 2008
652008
Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts.
S Moreira, Branco, Sampaio, Cunha-Oliveira, Martins, Holy, Oliveira
Biochim Biophys Acta 1842 (12 Pt A), 2468-78, 2014
63*2014
Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts.
S Moreira, Branco, Sampaio, Cunha-Oliveira, Martins, Holy, Oliveira
Biochim Biophys Acta 1842 (12 Pt A), 2468-78, 2014
63*2014
The system can't perform the operation now. Try again later.
Articles 1–20